Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT

NCT02735317 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Neoplasms
Stomatitis

Interventions

DRUG: Oral Ulcer Gargle (FORRAD®)
DRUG: Quadruple mixture, composed of dexamethasone, gentamicin, vitamin B12, and procaine

Sponsor

Yun-fei Xia